Harris Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-878
| Closed | -$631K | – | 146 |
|
|
2023
Q2 | $631K | Sell |
878
-1,008
| -53% | -$724K | ﹤0.01% | 130 |
|
|
2023
Q1 | $1.55M | Sell |
1,886
-87,753
| -98% | -$72.1M | ﹤0.01% | 122 |
|
|
2022
Q4 | $64.7M | Sell |
89,639
-98,537
| -52% | -$71.1M | 0.13% | 91 |
|
|
2022
Q3 | $130M | Sell |
188,176
-394,450
| -68% | -$272M | 0.22% | 79 |
|
|
2022
Q2 | $344M | Sell |
582,626
-510,391
| -47% | -$302M | 0.55% | 52 |
|
|
2022
Q1 | $763M | Sell |
1,093,017
-228,302
| -17% | -$159M | 1.01% | 28 |
|
|
2021
Q4 | $834M | Sell |
1,321,319
-4,977
| -0.4% | -$3.14M | 1.3% | 24 |
|
|
2021
Q3 | $803M | Sell |
1,326,296
-118,757
| -8% | -$71.9M | 1.28% | 26 |
|
|
2021
Q2 | $807M | Buy |
1,445,053
+411,475
| +40% | +$230M | 1.29% | 26 |
|
|
2021
Q1 | $489M | Buy |
1,033,578
+505,448
| +96% | +$239M | 0.84% | 44 |
|
|
2020
Q4 | $255M | Sell |
528,130
-138,165
| -21% | -$66.7M | 0.49% | 58 |
|
|
2020
Q3 | $373M | Sell |
666,295
-560,926
| -46% | -$314M | 0.91% | 37 |
|
|
2020
Q2 | $765M | Sell |
1,227,221
-1,089,797
| -47% | -$680M | 1.86% | 18 |
|
|
2020
Q1 | $1.13B | Sell |
2,317,018
-2,049,828
| -47% | -$1B | 3.13% | 7 |
|
|
2019
Q4 | $1.64B | Buy |
4,366,846
+225,394
| +5% | +$84.6M | 2.91% | 8 |
|
|
2019
Q3 | $1.15B | Buy |
4,141,452
+226,733
| +6% | +$62.9M | 2.23% | 13 |
|
|
2019
Q2 | $1.23B | Buy |
3,914,719
+1,247,748
| +47% | +$391M | 2.25% | 11 |
|
|
2019
Q1 | $1.1B | Sell |
2,666,971
-344,437
| -11% | -$141M | 2.01% | 12 |
|
|
2018
Q4 | $1.12B | Sell |
3,011,408
-162,236
| -5% | -$60.6M | 2.27% | 9 |
|
|
2018
Q3 | $1.28B | Buy |
3,173,644
+24,967
| +0.8% | +$10.1M | 2.01% | 13 |
|
|
2018
Q2 | $1.09B | Buy |
3,148,677
+1,448,644
| +85% | +$500M | 1.76% | 16 |
|
|
2018
Q1 | $585M | Buy |
+1,700,033
| New | +$585M | 0.98% | 38 |
|